Methylene diphenyl isocyanate (MDI) is a key isocyanate compound used chiefly to produce polyurethane foams that find application in insulation, cushioning, and composite materials. The same chemical underpins the adhesive technology that binds particle board—a staple of modern residential construction—into a cohesive panel. Because inhalation of MDI fumes poses serious health risks, its use is tightly regulated in industrial settings.
MDI belongs to the isocyanate family and represents approximately 94 % of all isocyanate production in the United States. At ambient temperature the material is a solid, but it is typically melted and handled as a liquid during manufacturing. The synthesis pathway begins with the condensation of aniline and formaldehyde to form diphenylmethane diamine, followed by phosgenation to yield MDI.
MDI serves as a core intermediate for a range of polyurethane products. Roughly 53 % of its output is dedicated to rigid polyurethane foam, which provides thermal insulation and structural cushioning in buildings, appliances, and transportation vehicles. Other major uses include flexible foams, binders, elastomers, adhesives, sealants, surface coatings, and fibers. In the wood products sector, MDI‑based polyurethane adhesives bind wood chips and flakes to create particle board.
Over 80 % of the world’s MDI supply is produced by a handful of leading manufacturers—ARCO Chemical, BASF, Bayer, Dow Chemical, Geismar, and ICI—making them the sole U.S. producers of the chemical. Dow, in particular, operates facilities across multiple continents, including Yeosu (South Korea), Yokkaichi/Kinu Ura (Japan), Stade (Germany), Delfzijl (Netherlands), and Estarreja (Portugal).
Industrial environments are the primary source of MDI exposure, predominantly through inhalation of vapors and dermal contact. Under federal OSHA regulations, facilities that handle MDI must employ closed‑system processes, provide adequate exhaust ventilation, and maintain continuous monitoring with alarm and shutdown systems. Because the precursor chemicals—formaldehyde (a probable human carcinogen and reproductive hazard) and phosgene (a lethal gas at low concentrations)—are also high‑hazard substances, manufacturers are required to implement rigorous safety protocols.
Inhalation of MDI vapors can trigger coughing, wheezing, chest tightness, and shortness of breath. The chemical is considered immediately dangerous at concentrations above 7.5 ppm, while the current permissible exposure limit set by OSHA is 0.02 ppm. Skin contact may cause severe irritation and rash. Long‑term, chronic exposure has been linked to asthma, dyspnea, and other respiratory disorders among workers. The U.S. Environmental Protection Agency classifies MDI as Group D—meaning it is not classifiable as to human carcinogenicity.
